hhvb glp 1 reviews MinuteClinic® Weight Loss Program, which may include GLP-1 FDA approved medications New Eli Lilly trial suggests
Description
A 2023 observational analysis published in the Annals of the Rheumatic Diseases found that patients with inflammatory arthritis who used GLP-1 receptor agonists had lower rates of cardiovascular events, which is notable because cardiovascular disease is a leading cause of death in RA patients
After all, GLP-1 is a hormone so perhaps GLP-1RAs (tirzepatide in this case) should be part of a comprehensive hormone therapy
,aspect=ignore)
Discussion GLP-1RA fills increased rapidly between 2018 and 2023
GLP-1 patches may be trending, but theyre not a medically recognised treatment
